Agree. Share price is 52 weeks low. I would like all Directors to buy some shares. Also this will give confidence to some shareholders.Can anyone confirm if David Kaysen is based in US or Australia ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025